Trial characteristics of the Non-inferiority trials studied.

NIAID Data Ecosystem2026-03-08 收录

下载链接：

https://figshare.com/articles/dataset/_Trial_characteristics_of_the_Non_inferiority_trials_studied_/1123617

下载链接

链接失效反馈

官方服务：

资源简介：

Trial characteristics of the Non-inferiority trials studied.

创建时间：

2014-07-31

Study characteristics of non-inferiority trials in ARV-experienced patients.

*81% ARV-experienced patients in the study; LLOQ = Lower limit of quantitation; 3TC = Lamivudine; ZDV = Zidovudine; APV = Amprenavir; RTV = Ritonavir; FTC = Emtricitabine; d4T = Stavudine; DRV = Darun

Figshare2015-12-02 更新00

Study characteristics of non-inferiority trials in ARV-experienced patients.

NIAID Data Ecosystem20

Sample size calculations for non-inferiority trials.

Efficacy in the reference arm from 80%–95%, delta 5–10%, alpha error 0.01, power 90%. The Non-inferiority margin represents the smallest acceptable difference with respect to the success rate with the

NIAID Data Ecosystem40

Study characteristics of non-inferiority trials in ARV-naive patients.

Plac = placebo; TLOVR = time to loss of virologic response; TDF = Tenofovir DF; 3TC = Lamivudine; EFV = Efavirenz; d4T = Stavudine; ABC = Abacavir; ZDV = Zidovudine; FPV = Fosamprenavir; RTV = Ritonav

Figshare2015-12-02 更新00

Study characteristics of non-inferiority trials in ARV-naive patients.

NIAID Data Ecosystem40